Search

everythinglearnresearchcommunity

for

Search:↓

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Melanin may help melanoma cells grow by aiding their metabolism.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

AMFIBHA scaffold significantly healed large full-thickness burn wounds in rabbits and restored skin's mechanical properties.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Alopecia is not a significant predictor of thyroid disease when age and sex are considered.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

A specific mutation in the K25 gene causes a rare genetic disorder with curly hair at birth and later hair loss, along with dental issues.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

A specific genetic change in the KRT71 gene causes a hair loss condition in Hereford cattle.

Rural Bangladeshi girls mature later than peers in other low and middle-income countries due to poor nutrition and socioeconomic conditions.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

PRP shows promise for treating hair loss, but more research is needed.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Getting the right amount of selenium is important for health; too little can cause disease, and too much can lead to toxicity.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Psychological stress and personal history are significant factors in hair loss.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

More oxygen isn't always better and can sometimes be worse.